341 related articles for article (PubMed ID: 31359232)
1. Impact of lesion angle on optical coherence tomography findings and clinical outcomes after drug-eluting stent implantation in curved vessels.
Nakamura S; Kimura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hishikari K; Hikita H; Takahashi A; Hirao K
Int J Cardiovasc Imaging; 2019 Dec; 35(12):2147-2155. PubMed ID: 31359232
[TBL] [Abstract][Full Text] [Related]
2. Impacts of lesion angle on incidence and distribution of acute vessel wall injuries and strut malapposition after drug-eluting stent implantation assessed by optical coherence tomography.
Minami Y; Ong DS; Uemura S; Wang Z; Aguirre AD; Mukhopadhyay S; Soeda T; Vergallo R; Jia H; Tian J; Hu S; Kim SJ; Park CB; Dauerman HL; Lee S; Jang IK
Eur Heart J Cardiovasc Imaging; 2015 Dec; 16(12):1390-8. PubMed ID: 25925215
[TBL] [Abstract][Full Text] [Related]
3. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
[TBL] [Abstract][Full Text] [Related]
4. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
5. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
6. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
[TBL] [Abstract][Full Text] [Related]
7. Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.
Ishida K; Otsuki S; Giacchi G; Ortega-Paz L; Shiratori Y; Freixa X; Martín-Yuste V; Masotti M; Sabaté M; Brugaletta S
Cardiovasc Revasc Med; 2017; 18(1):47-52. PubMed ID: 27634493
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.
Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Dec; 28(8):1887-94. PubMed ID: 22447206
[TBL] [Abstract][Full Text] [Related]
9. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
[TBL] [Abstract][Full Text] [Related]
10. Early Strut Coverage in Patients Receiving Drug-Eluting Stents and its Implications for Dual Antiplatelet Therapy: A Randomized Trial.
Lee SY; Kim JS; Yoon HJ; Hur SH; Lee SG; Kim JW; Hong YJ; Kim KS; Choi SY; Shin DH; Nam CM; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
JACC Cardiovasc Imaging; 2018 Dec; 11(12):1810-1819. PubMed ID: 29454763
[TBL] [Abstract][Full Text] [Related]
11. Early Follow-Up Optical Coherence Tomographic Findings of Significant Drug-Eluting Stent Malapposition.
Lee SY; Ahn CM; Yoon HJ; Hur SH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Circ Cardiovasc Interv; 2018 Dec; 11(12):e007192. PubMed ID: 30562088
[TBL] [Abstract][Full Text] [Related]
12. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
[TBL] [Abstract][Full Text] [Related]
13. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF
Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518
[TBL] [Abstract][Full Text] [Related]
14. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
[TBL] [Abstract][Full Text] [Related]
15. Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
Choi W; Chae IH; Park JJ; Kim SH; Kang SH; Oh IY; Yoon CH; Cho YS; Youn TJ; Choi DJ
Korean J Intern Med; 2019 Jul; 34(4):819-829. PubMed ID: 29961306
[TBL] [Abstract][Full Text] [Related]
16. Very late-phase vascular response after everolimus-eluting stent implantation assessed by optical coherence tomography.
Khalifa AKM; Ino Y; Kubo T; Tanimoto T; Shimamura K; Shiono Y; Takahata M; Terada K; Higashioka D; Wada T; Taruya A; Emori H; Katayama Y; Kashiwagi M; Kuroi A; Matsuo Y; Fujita S; Tanaka A; Hozumi T; Akasaka T
Int J Cardiovasc Imaging; 2020 Sep; 36(9):1627-1635. PubMed ID: 32385540
[TBL] [Abstract][Full Text] [Related]
17. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
18. Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study.
Giglioli C; Formentini C; Romano SM; Cecchi E; Baldereschi GJ; Landi D; Chiostri M; Prati F; Marchionni N
Int J Cardiovasc Imaging; 2020 Feb; 36(2):217-230. PubMed ID: 31667661
[TBL] [Abstract][Full Text] [Related]
19. Difference of vascular healing between bioabsorbable-polymer and durable-polymer new generation drug-eluting stents: an optical coherence tomographic analysis.
Matsuhiro Y; Nakamura D; Shutta R; Kawamura A; Nakamura H; Okamoto N; Matsunaga-Lee Y; Yano M; Egami Y; Sakata Y; Nishino M; Tanouchi J
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1131-1141. PubMed ID: 33165669
[TBL] [Abstract][Full Text] [Related]
20. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
